REQUEST A DEMO
Total
USD $0.00
Search more companies

Abbott Medical Balkan Doo Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Abbott Medical Balkan Doo Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Abbott Medical Balkan Doo Beograd is a company in Serbia, with a head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on March 30, 2010. It currently has a total number of 12 (2020) employees. From the latest financial highlights, Abbott Medical Balkan Doo Beograd reported a net sales revenue increase of 26.38% in 2022. Its’ total assets recorded a growth of 30.31%. The net profit margin of Abbott Medical Balkan Doo Beograd increased by 1.83% in 2022.

Headquarters
Bulevar Mihaila Pupina 115 D
Belgrade; Belgrade; Postal Code: 11000

Contact Details: Purchase the Abbott Medical Balkan Doo Beograd report to view the information.

Website: http://www.sjm.com

Basic Information
Total Employees:
Purchase the Abbott Medical Balkan Doo Beograd report to view the information.
Outstanding Shares:
Purchase the Abbott Medical Balkan Doo Beograd report to view the information.
Registered Capital:
Purchase the Abbott Medical Balkan Doo Beograd report to view the information.
Incorporation Date:
March 30, 2010
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Abbott Medical Balkan Doo Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
26.38%
Total operating revenue
26.24%
Operating profit (EBIT)
156.49%
EBITDA
157.3%
Net Profit (Loss) for the Period
134.76%
Total assets
30.31%
Total equity
20.56%
Operating Profit Margin (ROS)
2.72%
Net Profit Margin
1.83%
Return on Equity (ROE)
6.78%
Quick Ratio
-0.12%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?